Compounds > tazobactam
Page last updated: 2024-09-03

tazobactam and d13-9001

tazobactam has been researched along with d13-9001 in 1 studies

Compound Research Comparison

Studies
(tazobactam)		Trials
(tazobactam)		Recent Studies (post-2010)
(tazobactam)		Studies
(d13-9001)		Trials
(d13-9001)		Recent Studies (post-2010) (d13-9001)
1,327153694503

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, SW; Dean, CR; Iartchouk, O; Jones, AK; Lee, PS; Mostafavi, M; Ranjitkar, S; Walker, JR; Willis, TW; Zwirko, Z1

Other Studies

1 other study(ies) available for tazobactam and d13-9001

ArticleYear
Target (MexB)- and Efflux-Based Mechanisms Decreasing the Effectiveness of the Efflux Pump Inhibitor D13-9001 in
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2

    Topics: beta-Lactams; Imipenem; Microbial Sensitivity Tests; Monobactams; Piperidines; Pseudomonas aeruginosa; Quaternary Ammonium Compounds; Tazobactam; Thienamycins; Transcriptome

2019